Invega Hafyera Flashcards
1
Q
Generic
A
Paliperidone palmitate
2
Q
Manufactured
A
Janssen
3
Q
Dosing
A
1092mg/3.5 mL
1560mg/5mL
4
Q
Supplied
A
Prefilled
20G, 1 1/2 inch needle
5
Q
Steady state
A
Estimated greater than a year
6
Q
Indications
A
6 months schizophrenia after
PP1m of Sustenna greater/equal than 4 months
PP3m of Trinza for one cycle
7
Q
Criteria prior
A
Must be treated prior with Sustenna equal or greater than 4 months or
One 3 month cycle of Trinza
8
Q
Loading dose
A
Recommended based on prior product dose
9
Q
Administration site
A
Gluteal IM
10
Q
Adverse reaction
A
Upper respiratory
Injection site
Weight increased
Headache
Parkinson’s
11
Q
Specific population
A
May cause EPS or withdrawal symptoms in neonates in third trimester
Not recommended for renal impatient
12
Q
Drug interaction
A
CYP3A5 inducers
P-gp inducers
13
Q
Storage
A
59-86F
